Siimes M A, Rautonen J
Children's Hospital, University of Helsinki, Finland.
Cancer. 1990 Mar 15;65(6):1303-6. doi: 10.1002/1097-0142(19900315)65:6<1303::aid-cncr2820650608>3.0.co;2-d.
Testicular size has been studied in 66 adult men who survived leukemia (n = 14) or cancer (n = 52) in childhood. Mean follow-up time was 14.5 years. The testicular size was measured as the length and breadth in mm; testicular volume index was calculated. Serum concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and prolactin were measured. A sperm sample was obtained from 46 men. The patients had smaller testicles than healthy medical students; 51 had small testicles. The size was the smallest in patients who survived leukemia. Multivariate analysis showed that the variables with independent effects on testicular size were cranial and testicular irradiation and therapy with cyclophosphamide. Sperm production was dependent on testicular size. We conclude that determination of serum FSH combined with testicular size may offer a practical approach for predicting the subsequent testicular damage in boys with malignancies.
对66名成年男性的睾丸大小进行了研究,这些男性在儿童时期曾患白血病(n = 14)或癌症(n = 52)并存活下来。平均随访时间为14.5年。睾丸大小以毫米为单位测量长和宽;计算睾丸体积指数。测量血清促卵泡激素(FSH)、促黄体生成素(LH)、睾酮和催乳素的浓度。从46名男性中获取了精液样本。这些患者的睾丸比健康医学生的小;51人睾丸较小。白血病存活患者的睾丸尺寸最小。多变量分析表明,对睾丸大小有独立影响的变量是头颅和睾丸照射以及环磷酰胺治疗。精子生成取决于睾丸大小。我们得出结论,血清FSH测定结合睾丸大小可能为预测患有恶性肿瘤男孩后续的睾丸损伤提供一种实用方法。